The use of quetiapine is appropriate for insomnia monotherapy in patients with anxiety and depressive disorders, chronic somatic diseases, including the elderly, at an initial dose of 25 mg. The presence of Quetixol (25 mg), a clinically bioequivalent original drug, makes it convenient and affordable to treat patients in this category.
The use of atypical neuroleptics in the practice of a family doctor. O.O. Haystova. Neuronus №8 (82), 2016